InnoCare Announces Company Secretary Transition Effective 25 March 2026

Bulletin Express
03/25

InnoCare Pharma Limited (InnoCare) has disclosed a forthcoming change in its senior corporate governance roles.

Ms. Lee Angel Pui Shan has tendered her resignation as Company Secretary, Authorised Representative under Listing Rule 3.05, and Process Agent under Part 16 of the Hong Kong Companies Ordinance. Her duties will conclude on 25 March 2026. According to the filing, Ms. Lee confirmed no disagreements with the Board and no matters requiring shareholder or Stock Exchange attention.

Effective the same date, Ms. Lin Sio Ngo will assume all three positions. Ms. Lin, currently a manager at SWCS Corporate Services Group (Hong Kong) Limited, brings more than 20 years of experience in corporate secretarial and administrative management. She has been an associate member of The Hong Kong Chartered Governance Institute and The Chartered Governance Institute since 2004, and holds both a bachelor’s degree in business administration and a master’s degree in corporate governance.

The Board expressed its gratitude to Ms. Lee for her service and welcomed Ms. Lin to her new roles.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10